Study of rifampin levels in patients with bone or joint staph infections
Part of Bones, joints & muscles, Infections clinical trials.
This study looks at how the antibiotic rifampin behaves in the body when used to treat staph infections in bones or joints. It may help doctors better dose the drug for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a staph infection in a bone or joint (like a hip, knee, or shoulder replacement infection, or a chronic bone infection).
- The infection must be treatable with rifampin plus either levofloxacin or ciprofloxacin.
- You must not have septic shock, severe liver disease, kidney failure requiring dialysis, or be pregnant or breastfeeding.
- You must be able to give written informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study explores what it's like for patients, their families, and healthcare providers dealing with an infection in a hip, knee, or shoulder replacement. The goal is to create a teaching program to help patients better manage their care.
This study tests whether adding the antibiotic rifampicin to standard treatment works better than standard treatment alone for staph infections in hip or knee replacements. The goal is to find a more effective way to clear the infection and avoid more surgeries.
This study measures how much of the antibiotic delafloxacin gets into skin, soft tissue, and bone in people with serious infections. It may help doctors understand if the drug reaches the infection site well enough to be effective.
This trial tests whether adding antibiotics to the bone graft used during hip replacement surgery can lower the risk of infection. It may help people who need a bone graft as part of their hip replacement.
This Phase 3 trial compares two antibiotics—rifabutin and rifampicin—for treating staphylococcal (staph) infections around hip or knee joint implants when the implant is kept in place after cleaning (DAIR). It aims to see which drug works better to stop the infection from coming back.
This trial tests whether adding a drug called probenecid can help amoxicillin work better in your body for treating bone and joint infections. If you are already taking amoxicillin for such an infection, adding probenecid might increase the amount of amoxicillin in your blood, potentially making the treatment more effective.
Hear when a new Prosthetic Joint Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.